Maxigen Biotech Inc. (1783) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Maxigen Biotech Inc. (1783:TWSE), powered by AI.

Current Price
$38.55
Sector
Healthcare
What is the Maxigen Biotech Inc. stock price forecast?

Maxigen Biotech Inc. is currently trading at $38.55. View real-time AI analysis on Alpha Lenz.

What is Maxigen Biotech Inc. insider trading activity?

View the latest insider trading data for Maxigen Biotech Inc. on Alpha Lenz.

What is Maxigen Biotech Inc.'s P/E ratio?

View Maxigen Biotech Inc.'s valuation metrics on Alpha Lenz.

Maxigen Biotech Inc.

TWSE · 1783
NT$38.55-0.15(-0.39%)
Ask about Maxigen Biotech Inc.'s future dividend policy...
Alpha Chat Insight

Maxigen Biotech Inc.'s ROE is 18.2%. Explore profitability and growth together.

Ask for details

Company Overview

Maxigen Biotech Inc. is a biotechnology company dedicated to the research, development, and commercialization of health and beauty products. Its primary focus is on producing innovative biomedical and cosmeceutical products that integrate both scientific and cosmetic benefits. The company's product portfolio includes pharmaceuticals, dietary supplements, skincare products, and functional cosmetics, all benefiting from its proprietary biotechnology advancements. Maxigen Biotech Inc. plays a significant role in the health and beauty industry by combining cutting-edge biotechnological research with consumer-focused applications. It serves diverse sectors, from healthcare and wellness to cosmetics, addressing consumer needs for effective and safe products with scientifically-backed efficacy. The company utilizes state-of-the-art laboratory processes to ensure the highest standards of product quality and performance. In the financial market, Maxigen Biotech Inc. represents an intersection of technology and consumer goods, offering investors insight into emerging trends in biotechnology and personal care. Its innovative approaches and commitment to integrating science with everyday products enhance its relevance and influence in both the biotech sphere and the wider consumer marketplace.

SectorHealthcare
IndustryMedical Instruments & Supplies
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$811.56MRevenue
0.00Shares Out
0Employees

Margins

69.46%Gross
40.63%EBITDA
31.26%Operating
37.57%Pre-Tax
32.69%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

10.32%Rev 3Yr
12.14%Rev 5Yr
23.92%Op Inc 3Yr
32.98%Op Inc 5Yr
23.93%Net Inc 3Yr
33.19%Net Inc 5Yr

Returns

15.27%ROA
18.22%ROE
17.55%ROIC

Financial Health

NT$576.19MCash & Cash Equivalents
NT$-220.65MNet Debt
23.12%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Maxigen Biotech Inc. (ticker: 1783) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies).

The current price is 38.55 with a P/E ratio of -x and P/B of -x.

ROE is 18.22% and operating margin is 31.26%. Annual revenue is $812M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Maxigen Biotech Inc. (1783) Stock Forecast 2026 $38.55 — Price, Financials & Analyst Targets | Alpha Lenz